United States Home Infusion Therapy Market Trends & Summary
Market Overview
The United States home infusion therapy market is projected to reach approximately US$ 20.59 billion by 2033, up from US$ 10.26 billion in 2024, with a compound annual growth rate (CAGR) of 8.05% from 2025 to 2033. This growth is driven by the increasing prevalence of chronic diseases, advancements in home healthcare technology, and a rising preference for cost-effective, patient-centric treatment options.
Free Download Sample Report: https://www.renub.com/request-sample-page.php?gturl=united-states-home-infusion-market-p.php
The report United States Home Infusion Therapy Market & Forecast covers:
- By Application: Anti-Infective, Endocrinology, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals, and Others.
- By Product: Infusion Pumps, Intravenous Sets, IV Cannulas, Needleless Connectors.
- By States and Company Analysis (2025-2033).
Market Insights
| Report Features | Details |
| Base Year | 2024 |
| Forecast Years | 2025 – 2033 |
| Historical Years | 2020 – 2024 |
| Market Size in 2024 | US$ 10.26 Billion |
| Market Forecast in 2033 | US$ 20.59 Billion |
| Market Growth Rate (2025-2033) | 8.05% |
United States Home Infusion Therapy Market Outlook
Home infusion therapy enables patients to receive intravenous (IV) or injectable medications at home rather than in a hospital or clinic. This approach provides treatments such as antibiotics, chemotherapy, pain management, and nutrition support in a more comfortable and cost-effective environment. The increasing preference for personalized healthcare solutions and technological advancements is driving significant market expansion.
Growth Drivers
1. Growing Prevalence of Chronic Diseases
- Rising cases of diabetes, cancer, and cardiovascular diseases necessitate long-term care.
- Home infusion therapy minimizes hospital stays, reducing healthcare costs.
- The U.S. Census Bureau estimates the 65+ population to reach 95 million by 2060, increasing the demand for home healthcare services.
- Medicare enrollment is projected to exceed 80 million beneficiaries by 2030, expanding the potential patient base.
2. Technological Advancements in Infusion Devices
- Development of portable infusion pumps and remote monitoring systems enhances treatment accuracy.
- The FDA-approved phase II study for OMN6 (Omnix Medical’s anti-infective drug) in November 2023 highlights innovation in home infusion therapies.
3. Patient-Centered Care on the Rise
- Patients prefer receiving treatments in a familiar, comfortable home environment.
- A study by BioMatrix Specialty Pharmacy (March 2023) reported that home infusion therapy reduces infection risks and improves mental health.
- Cost savings for both patients and healthcare providers make home infusion an attractive alternative.
Market Challenges
1. High Costs of Infusion Equipment and Therapies
- Expensive infusion devices and medications pose financial challenges.
- Complex insurance reimbursement processes hinder widespread accessibility.
2. Limited Skilled Workforce Availability
- Shortage of trained nurses and pharmacists affects service quality.
- Rural areas face difficulties in accessing skilled professionals for home care services.
Key Market Segments
By Application
- Anti-Infective
- Endocrinology
- Hydration Therapy
- Chemotherapy
- Enteral Nutrition
- Parenteral Nutrition
- Specialty Pharmaceuticals
- Others
By Product
- Infusion Pumps
- Intravenous Sets
- IV Cannulas
- Needleless Connectors
By State (Top 5)
- California
- Texas
- New York
- Florida
- Illinois
Regional Analysis
California Home Infusion Therapy Market
- Large population and advanced healthcare infrastructure support market growth.
- High prevalence of chronic diseases increases demand.
New York Home Infusion Therapy Market
- Growing adoption of home-based treatments to reduce hospital congestion.
- Expansion of home healthcare services benefits both urban and rural communities.
Texas Home Infusion Therapy Market
- Increasing chronic disease cases drive demand.
- State initiatives focus on improving healthcare access, especially in rural areas.
Florida Home Infusion Therapy Market
- Aging population drives market expansion.
- Focus on cost-effective and patient-centered care solutions.
Key Companies Analyzed
Covered Companies (3 Viewpoints: Overview, Recent Development, Revenue)
- Baxter International Inc.
- Becton Dickinson and Company
- Eli Lilly & Company
- Fresenius SE & Co. KGaA
- ICU Medical Inc.
- Option Care Health Inc.
- Terumo Corporation
Conclusion
The United States home infusion therapy market is experiencing robust growth, driven by chronic disease prevalence, technological advancements, and increased adoption of home healthcare services. While challenges like high costs and workforce shortages persist, innovations in infusion devices and personalized patient care models are expected to propel the market forward. As healthcare shifts towards more cost-effective and patient-centric solutions, home infusion therapy is poised to play a crucial role in the future of U.S. healthcare.
About Us
Renub Research is a leading market research and advisory firm with over 15 years of experience in providing business-to-business global market research, business surveys, and management consulting. Our firm is dedicated to offering a comprehensive suite of services tailored to help businesses make informed decisions.
We partner with our clients to identify their greatest opportunities, address pressing issues, and navigate the changes required to drive success. Our clients span across various high-stakes industries such as Healthcare, Travel & Tourism, Food & Beverages, Power & Energy, Information Technology, Telecoms & Internet, Chemicals, Logistics & Automotive, Consumer Goods & Retail, Building & Construction, and Agriculture.
Our Expertise
Renub Research is trusted by top global organizations for our deep insights, actionable market information, and precise market data that empower our clients to make well-informed decisions. We are a well-established provider of industry solutions, and our research is pivotal in assisting consultants, bankers, and executives with crafting solid business strategies.
Our team consists of highly skilled professionals with expertise in finance, marketing, human resources, biotechnology, pharmaceuticals, IT, environmental science, and other related fields. The studies we conduct form the foundation of management decisions, including strategies, organizational structures, activities, technology use, and merger and acquisition opportunities.
Why Choose Renub Research?
- Comprehensive Market Insights: Our reports provide detailed information and insights on opportunities and trends across various industries.
- Strategic Analysis: We deliver in-depth analysis, helping companies understand market dynamics and competitive positioning.
- Accurate Forecasting: Our forecast and estimation methodologies ensure that managers have reliable data to make decisions in a rapidly changing global economy.
With a solid reputation for delivering impactful research, Renub Research is proud to support a number of global players by providing not only IT solutions but also comprehensive overviews of market opportunities. Our research empowers companies to stay ahead in the competitive global landscape.
